Why 21? the significance of selenoproteins for human health revealed by inborn errors of metabolism

FASEB Journal

Volumn 30, Issue 11, 2016, Pages 3669-3681

  Schweizer, Ulrich ^a   Fradejas Villar, Noelia ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Brain Development; Deiodinase; Epilepsy; Interneuron; Sedaghatian

Indexed keywords

PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; SELENIUM; SELENOPROTEIN; SELENOPROTEIN N; SERINE TRANSFER RNA; THIOREDOXIN; THYROID HORMONE; UNCLASSIFIED DRUG; SELENOCYSTEINE;

ADRENAL DISEASE; ARTICLE; BIOSYNTHESIS; BONE DEVELOPMENT; BRAIN DISEASE; CHONDRODYSPLASIA; DEGENERATIVE DISEASE; GENE MUTATION; GENETIC DISORDER; HEART DISEASE; HUMAN; INBORN ERROR OF METABOLISM; INNER EAR; MYOPATHY; NEUROLOGIC DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; SELENIUM DEFICIENCY; SPONDYLOMETAPHYSEAL CHONDRODYSPLASIA SEDAGHATIAN TYPE; TRANSGENIC MOUSE; ANIMAL; DEFICIENCY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METABOLISM, INBORN ERRORS; MUTATION; SELENIUM; SELENOCYSTEINE; SELENOPROTEINS;

EID: 84995535984     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201600424     Document Type: Article

References (103)

1. Zinoni, F., Birkmann, A., Leinfelder, W., and Böck, A. (1987) Cotranslational insertion of selenocysteine into formate dehydrogenase from Escherichia coli directed by a UGA codon. Proc. Natl. Acad. Sci. USA 84, 3156-3160
2. Chambers, I., Frampton, J., Goldfarb, P., Affara, N., McBain, W., and Harrison, P. R. (1986) The structure of the mouse glutathione peroxidase gene: The selenocysteine in the active site is encoded by the 'termination' codon, TGA. EMBO J. 5, 1221-1227
3. Böck, A., Forchhammer, K., Heider, J., and Baron, C. (1991) Selenoprotein synthesis: An expansion of the genetic code. Trends Biochem. Sci. 16, 463-467
4. Berry, M. J., Banu, L., Chen, Y. Y., Mandel, S. J., Kieffer, J. D., Harney, J. W., and Larsen, P. R. (1991) Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 39 untranslated region. Nature 353, 273-276
5. Fagegaltier, D., Hubert, N., Yamada, K., Mizutani, T., Carbon, P., and Krol, A. (2000) Characterization of mSelB, a novel mammalian elongation factor for selenoprotein translation. EMBO J. 19, 4796-4805
6. Copeland, P. R., Fletcher, J. E., Carlson, B. A., Hatfield, D. L., and Driscoll, D. M. (2000) A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. EMBO J. 19, 306-314
7. Howard, M. T., Aggarwal, G., Anderson, C. B., Khatri, S., Flanigan, K.M., and Atkins, J. F. (2005) Recoding elements located adjacent to a subset of eukaryal selenocysteine-specifyingUGAcodons.EMBO J. 24, 1596-1607
8. Xu, X. M., Carlson, B. A., Mix, H., Zhang, Y., Saira, K., Glass, R. S., Berry, M. J., Gladyshev, V.N., andHatfield, D.L. (2007) Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol. 5, e4
9. Yuan, J., Palioura, S., Salazar, J. C., Su, D., O'Donoghue, P., Hohn, M. J., Cardoso, A. M., Whitman, W. B., and Söll, D. (2006) RNAdependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea. Proc. Natl. Acad. Sci. USA 103, 18923-18927
10. Hao, B., Gong, W., Ferguson, T. K., James, C. M., Krzycki, J. A., and Chan, M. K. (2002) A new UAG-encoded residue in the structure of a methanogen methyltransferase. Science 296, 1462-1466
11. Srinivasan, G., James, C. M., and Krzycki, J. A. (2002) Pyrrolysine encoded by UAG in Archaea: charging of a UAG-decoding specialized tRNA. Science 296, 1459-1462
12. Kryukov, G. V., Castellano, S., Novoselov, S. V., Lobanov, A. V., Zehtab, O., Guiǵo, R., andGladyshev, V.N. (2003) Characterization of mammalian selenoproteomes. Science 300, 1439-1443
13. Labunskyy, V. M., Hatfield, D. L., and Gladyshev, V. N. (2014) Selenoproteins:molecular pathways and physiological roles. Physiol. Rev. 94, 739-777
14. Hatfield, D. L., Tsuji, P. A., Carlson, B. A., and Gladyshev, V. N. (2014) Selenium and selenocysteine: roles in cancer, health, and development. Trends Biochem. Sci. 39, 112-120
15. Moghadaszadeh, B., Petit, N., Jaillard, C., Brockington, M., QuijanoRoy, S., Merlini, L., Romero, N., Estournet, B., Desguerre, I., Chaigne, D., Muntoni, F., Topaloglu, H., and Guicheney, P. (2001) Mutations in SEPN1 cause congenitalmuscular dystrophywithspinal rigidity and restrictive respiratory syndrome. Nat. Genet. 29, 17-18
16. Castets, P., Lescure, A., Guicheney, P., and Allamand, V. (2012) SelenoproteinNin skeletalmuscle: fromdiseases to function. J. Mol. Med. 90, 1095-1107
17. Allamand, V., Richard, P., Lescure, A., Ledeuil, C., Desjardin, D., Petit, N., Gartioux, C., Ferreiro, A., Krol, A., Pellegrini, N., Urtizberea, J. A., and Guicheney, P. (2006) A single homozygous point mutation in a 3' untranslated region motif of selenoprotein N mRNA causes SEPN1-related myopathy. EMBO Rep. 7, 450-454
18. Maiti, B., Arbogast, S., Allamand, V., Moyle, M. W., Anderson, C. B., Richard, P., Guicheney, P., Ferreiro, A., Flanigan, K. M., and Howard, M. T. (2009) A mutation in the SEPN1 selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads to SEPN1-related myopathy. Hum. Mutat. 30, 411-416
19. Muth, O. H., Oldfield, J. E., Remmert, L. F., and Schubert, J. R. (1958) Effects of selenium and vitamin E on white muscle disease. Science 128, 1090
20. Kien, C. L., and Ganther, H. E. (1983) Manifestations of chronic selenium deficiency in a child receiving total parenteral nutrition. Am. J. Clin.Nutr. 37, 319-328
21. Brown, M. R., Cohen, H. J., Lyons, J.M., Curtis, T.W., Thunberg, B., Cochran, W. J., and Klish, W. J. (1986) Proximal muscle weakness and selenium deficiency associated with long term parenteral nutrition. Am. J. Clin. Nutr. 43, 549-554
22. Liu, J., and Rozovsky, S. (2015) Membrane-bound selenoproteins. Antioxid. Redox Signal. 23, 795-813
23. Jurynec, M. J., Xia, R., Mackrill, J. J., Gunther, D., Crawford, T., Flanigan, K. M., Abramson, J. J., Howard, M. T., andGrunwald, D. J. (2008) Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle. Proc. Natl. Acad. Sci. USA 105, 12485-12490
24. Rederstorff, M., Castets, P., Arbogast, S., Laińe, J., Vassilopoulos, S., Beuvin, M., Dubourg, O., Vignaud, A., Ferry, A., Krol, A., Allamand, V., Guicheney, P., Ferreiro, A., and Lescure, A. (2011) Increased muscle stress-sensitivity induced by selenoprotein N inactivation in mouse: Amammalian model for SEPN1-relatedmyopathy. PLoS One 6, e23094
25. Weber, G.F., Maertens, P., Meng, X. Z., andPippenger, C. E. (1991) Glutathione peroxidase deficiency and childhood seizures. Lancet 337, 1443-1444
26. Ramaekers, V. T., Calomme, M., Vanden Berghe, D., and Makropoulos, W. (1994) Selenium deficiency triggering intractable seizures. Neuropediatrics 25, 217-223
27. Beutler, E., Curnutte, J. T., and Forman, L. (1991) Glutathione peroxidase deficiency and childhood seizures. Lancet 338, 700
28. Schweizer, U., Bräuer, A. U., Köhrle, J., Nitsch, R., and Savaskan, N. E. (2004) Selenium and brain function: A poorly recognized liaison. Brain Res. Brain Res. Rev. 45, 164-178
29. Zachara, B.A., and Pilecki, A. (2001)Daily seleniumintakeby breastfed infants and the selenium concentration in the milk of lactating women in western Poland. Med. Sci. Monit. 7, 1002-1004
30. Behne, D., Hilmert, H., Scheid, S., Gessner, H., and Elger, W. (1988) Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochim. Biophys. Acta 966, 12-21
31. Bermano, G., Nicol, F., Dyer, J. A., Sunde, R. A., Beckett, G. J., Arthur, J. R., andHesketh, J. E. (1995) Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. Biochem. J. 311, 425-430
32. Schomburg, L., Schweizer, U., Holtmann, B., Flohe, L., Sendtner, M., and Köhrle, J. (2003) Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem. J. 370, 397-402
33. Hill, K. E., Zhou, J., McMahan, W. J., Motley, A. K., Atkins, J. F., Gesteland, R. F., and Burk, R. F. (2003) Deletion of selenoprotein P alters distribution of selenium in the mouse. J. Biol. Chem. 278, 13640-13646
34. Pitts, M. W., Raman, A. V., Hashimoto, A. C., Todorovic, C., Nichols, R. A., and Berry, M. J. (2012) Deletion of selenoprotein P results in impaired function of parvalbumin interneurons and alterations in fear learning and sensorimotor gating. Neuroscience 208, 58-68
35. Schweizer, U., Michaelis, M., Köhrle, J., and Schomburg, L. (2004) Efficient selenium transfer from mother to offspring in selenoprotein-P-deficient mice enables dose-dependent rescue of phenotypes associated with selenium deficiency. Biochem. J. 378, 21-26
36. Hill, K. E., Zhou, J., McMahan, W. J., Motley, A. K., and Burk, R. F. (2004) Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene. J. Nutr. 134, 157-161
37. Valentine, W. M., Hill, K. E., Austin, L. M., Valentine, H. L., Goldowitz, D., and Burk, R. F. (2005) Brainstem axonal degeneration in mice with deletion of selenoprotein p. Toxicol. Pathol. 33, 570-576
38. Schweizer, U., Streckfuss, F., Pelt, P., Carlson, B. A., Hatfield, D. L., Köhrle, J., and Schomburg, L. (2005) Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem. J. 386, 221-226
39. Peters, M. M., Hill, K. E., Burk, R. F., andWeeber, E. J. (2006)Altered hippocampus synaptic function in selenoprotein P deficient mice. Mol. Neurodegener. 1, 12
40. Renko, K., Werner, M., Renner-Müller, I., Cooper, T. G., Yeung, C. H., Hollenbach, B., Scharpf, M., Köhrle, J., Schomburg, L., and Schweizer, U. (2008) Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice. Biochem. J. 409, 741-749
41. Burk, R. F., andHill, K. E. (2015)Regulationof seleniummetabolism and transport. Annu. Rev. Nutr. 35, 109-134
42. Olson, G. E., Winfrey, V. P., Nagdas, S. K., Hill, K. E., and Burk, R. F. (2007) Apolipoprotein E receptor-2 (ApoER2) mediates selenium uptake from selenoprotein P by the mouse testis. J. Biol. Chem. 282, 12290-12297
43. Burk, R. F., Hill, K. E., Olson, G. E., Weeber, E. J., Motley, A. K., Winfrey, V. P., andAustin, L.M. (2007)Deletion of apolipoproteinE receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed. J. Neurosci. 27, 6207-6211
44. Valentine, W.M., Abel, T.W., Hill, K. E., Austin, L. M., and Burk, R. F. (2008) Neurodegeneration inmice resulting fromloss of functional selenoprotein P or its receptor apolipoprotein E receptor 2. J. Neuropathol. Exp. Neurol. 67, 68-77
45. Wang, L., Wang, X., Laird, N., Zuckerman, B., Stubblefield, P., and Xu, X. (2006) Polymorphism in maternal LRP8 gene is associated with fetal growth. Am. J. Hum. Genet. 78, 770-777
46. Olson, G.E., Winfrey, V.P., Hill, K.E., andBurk, R. F. (2008)Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells. J. Biol. Chem. 283, 6854-6860
47. Chiu-Ugalde, J., Theilig, F., Behrends, T., Drebes, J., Sieland, C., Subbarayal, P., Köhrle, J., Hammes, A., Schomburg, L., and Schweizer, U. (2010) Mutation of megalin leads to urinary loss of selenoprotein P and selenium deficiency in serum, liver, kidneys and brain. Biochem. J. 431, 103-111
48. Kurokawa, S., Eriksson, S., Rose, K. L., Wu, S., Motley, A. K., Hill, S., Winfrey, V. P., McDonald, W.H., Capecchi, M.R., Atkins, J. F., Arńer, E. S., Hill, K. E., and Burk, R. F. (2014) Sepp1(UF) forms are N-Terminal selenoprotein P truncations that have peroxidase activity when coupled with thioredoxin reductase-1. Free Radic. Biol.Med. 69, 67-76
49. Kantarci, S., Al-Gazali, L., Hill, R. S., Donnai, D., Black, G. C., Bieth, E., Chassaing, N., Lacombe, D., Devriendt, K., Teebi, A., Loscertales, M., Robson, C., Liu, T., MacLaughlin, D.T., Noonan, K. M., Russell, M. K., Walsh, C. A., Donahoe, P. K., and Pober, B. R. (2007) Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-Acoustico-renal syndromes. Nat. Genet. 39, 957-959
50. Zhang, Y., Zhou, Y., Schweizer, U., Savaskan, N. E., Hua, D., Kipnis, J., Hatfield, D. L., and Gladyshev, V. N. (2008) Comparative analysis of selenocysteine machinery and selenoproteome gene expression in mouse brain identifies neurons as key functional sites of selenium in mammals. J. Biol. Chem. 283, 2427-2438
51. Wirth, E.K., Conrad, M., Winterer, J., Wozny, C., Carlson, B.A., Roth, S., Schmitz, D., Bornkamm, G. W., Coppola, V., Tessarollo, L., Schomburg, L., Köhrle, J., Hatfield, D. L., and Schweizer, U. (2010) Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration. FASEB J. 24, 844-852
52. Seiler, A., Schneider, M., Förster, H., Roth, S., Wirth, E. K., Culmsee, C., Plesnila, N., Kremmer, E., Radmark, O., Wurst, W., Bornkamm, G. W., Schweizer, U., and Conrad, M. (2008) Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent-And AIF-mediated cell death. Cell Metab. 8, 237-248
53. Roth, S., Zhang, S., Chiu, J., Wirth, E. K., and Schweizer, U. (2010) Development of a serum-free supplement for primary neuron culture reveals the interplay of selenium and vitamin E in neuronal survival. J. Trace Elem. Med. Biol. 24, 130-137
54. Wirth, E. K., Bharathi, B. S., Hatfield, D., Conrad, M., Brielmeier, M., and Schweizer, U. (2014) Cerebellar hypoplasia in mice lacking selenoprotein biosynthesis in neurons. Biol. Trace Elem. Res. 158, 203-210
55. Carlson, B. A., Schweizer, U., Perella, C., Shrimali, R. K., Feigenbaum, L., Shen, L., Speransky, S., Floss, T., Jeong, S. J., Watts, J., Hoffmann, V., Combs, G. F., Gladyshev, V. N., and Hatfield, D. L. (2009) The selenocysteine tRNA STAF-binding region is essential for adequate selenocysteine tRNA status, selenoprotein expression and early age survival of mice. Biochem. J. 418, 61-71
56. Kasaikina, M. V., Turanov, A. A., Avanesov, A., Schweizer, U., Seeher, S., Bronson, R. T., Novoselov, S. N., Carlson, B. A., Hatfield, D. L., and Gladyshev, V. N. (2013) Contrasting roles of dietary selenium and selenoproteins in chemically induced hepatocarcinogenesis. Carcinogenesis 34, 1089-1095
57. Carlson, B.A., Yoo, M. H., Tsuji, P. A., Gladyshev, V.N., andHatfield, D. L. (2009) Mousemodels targeting selenocysteine tRNAexpression for elucidating the role of selenoproteins inhealthanddevelopment. Molecules 14, 3509-3527
58. Yoo, S. E., Chen, L., Na, R., Liu, Y., Rios, C., Van Remmen, H., Richardson, A., and Ran, Q. (2012) Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain. Free Radic. Biol. Med. 52, 1820-1827
59. Chen, L., Hambright, W. S., Na, R., and Ran, Q. (2015) Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapidmotor neuron degeneration and paralysis. J. Biol. Chem. 290, 28097-28106
60. Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., Basavarajappa, D., Radmark, O., Kobayashi, S., Seibt, T., Beck, H., Neff, F., Esposito, I., Wanke, R., Förster, H., Yefremova, O., Heinrichmeyer, M., Bornkamm, G. W., Geissler, E. K., Thomas, S. B., Stockwell, B. R., O'Donnell, V. B., Kagan, V. E., Schick, J. A., and Conrad, M. (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure inmice. Nat. Cell Biol. 16, 1180-1191
61. Castex, M. T., Arabo, A., Benard, M., Roy, V., Le Joncour, V., Pŕevost, G., Bonnet, J. J., Anouar, Y., andFalluel-Morel, A.(2015)Selenoprotein T deficiency leads to neurodevelopmental abnormalities and hyperactive behavior in mice. [E-pub ahead of print] Mol. Neurobiol. doi:10.1007/s12035-015-9505-7
62. Seeher, S., Carlson, B.A., Miniard, A.C., Wirth, E. K., Mahdi, Y., Hatfield, D. L., Driscoll, D. M., and Schweizer, U. (2014) Impaired selenoprotein expression in brain triggers striatal neuronal loss leading to co-ordination defects inmice. Biochem. J. 462, 67-75
63. Ben-Zeev, B., Hoffman, C., Lev, D., Watemberg, N., Malinger, G., Brand, N., and Lerman-Sagie, T. (2003) Progressive cerebellocerebral atrophy: A new syndrome with microcephaly, mental retardation, and spastic quadriplegia. J. Med. Genet. 40, e96
64. Agamy, O., Ben Zeev, B., Lev, D., Marcus, B., Fine, D., Su, D., Narkis, G., Ofir, R., Hoffmann, C., Leshinsky-Silver, E., Flusser, H., Sivan, S., Söll, D., Lerman-Sagie, T., and Birk, O. S. (2010) Mutations disrupting selenocysteine formation cause progressive cerebellocerebral atrophy. Am. J. Hum. Genet. 87, 538-544
65. Budde, B. S., Namavar, Y., Barth, P.G., Poll-The, B. T., Nürnberg, G., Becker, C., van Ruissen, F., Weterman, M. A., Fluiter, K., te Beek, E. T., Aronica, E., van der Knaap, M. S., Höhne, W., Toliat, M. R., Crow, Y. J., Steinling, M., Voit, T., Roelenso, F., Brussel, W., Brockmann, K., Kyllerman, M., Boltshauser, E., Hammersen, G., Willemsen, M., Basel-Vanagaite, L., Krägeloh-Mann, I., de Vries, L. S., Sztriha, L., Muntoni, F., Ferrie, C. D., Battini, R., Hennekam, R. C., Grillo, E., Beemer, F. A., Stoets, L. M., Wollnik, B., Nürnberg, P., and Baas, F. (2008) tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. Nat. Genet. 40, 1113-1118
66. Anttonen, A. K., Hilander, T., Linnankivi, T., Isohanni, P., French, R. L., Liu, Y., Simonovíc, M., Söll, D., Somer, M., Muth-Pawlak, D., Corthals, G. L., Laari, A., Ylikallio, E., Lähde, M., Valanne, L., Lönnqvist, T., Pihko, H., Paetau, A., Lehesjoki, A. E., Suomalainen, A., and Tyynismaa, H. (2015) Selenoprotein biosynthesis defect causes progressive encephalopathy with elevated lactate. Neurology 85, 306-315
67. Pavlidou, E., Salpietro, V., Phadke, R., Hargreaves, I. P., Batten, L., McElreavy, K., Pitt, M., Mankad, K., Wilson, C., Cutrupi, M. C., Ruggieri, M., McCormick, D., Saggar, A., and Kinali, M. (2016) Pontocerebellar hypoplasia type 2Dand optic nerve atrophy further expand the spectrum associated with selenoprotein biosynthesis deficiency. Eur. J. Paediatr. Neurol. 20, 483-488
68. Palioura, S., Sherrer, R. L., Steitz, T. A., Söll, D., and Simonovic, M. (2009) The human SepSecS-TRNASec complex reveals the mechanism of selenocysteine formation. Science 325, 321-325
69. Iwama, K., Sasaki, M., Hirabayashi, S., Ohba, C., Iwabuchi, E., Miyatake, S., Nakashima, M., Miyake, N., Ito, S., Saitsu, H., and Matsumoto, N. (2016) Milder progressive cerebellar atrophy caused by biallelic SEPSECS mutations. J. Hum. Genet. 61, 527-531
70. Sedaghatian, M. R. (1980) Congenital lethal metaphyseal chondrodysplasia: A newly recognized complex autosomal recessive disorder. Am. J. Med. Genet. 6, 269-274
71. Aygun, C., Celik, F. C., Nural, M. S., Azak, E., Kucukoduk, S., Ogur, G., and Incesu, L. (2012) Simplified gyral pattern with cerebellar hypoplasia in Sedaghatian type spondylometaphyseal dysplasia: A clinical report and review of the literature.Am. J.Med.Genet. A. 158A, 1400-1405
72. FORGE Canada Consortium. (2014) Mutations in the enzyme glutathione peroxidase 4 cause Sedaghatian-Type spondylometaphyseal dysplasia. J. Med. Genet. 51, 470-474
73. Fleming, C. R., Lie, J.T., McCall, J.T., O'Brien, J. F., Baillie, E.E., and Thistle, J.L. (1982) Seleniumdeficiency andfatal cardiomyopathy in a patient on home parenteral nutrition. Gastroenterology 83, 689-693
74. Loscalzo, J. (2014) Keshan disease, selenium deficiency, and the selenoproteome. N. Engl. J. Med. 370, 1756-1760
75. Collipp, P. J., and Chen, S. Y. (1981) Cardiomyopathy and selenium deficiency in a two-year-old girl. N. Engl. J. Med. 304, 1304-1305
76. Conrad, M., Jakupoglu, C., Moreno, S. G., Lippl, S., Banjac, A., Schneider, M., Beck, H., Hatzopoulos, A. K., Just, U., Sinowatz, F., Schmahl, W., Chien, K. R., Wurst, W., Bornkamm, G. W., and Brielmeier, M. (2004) Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol. Cell. Biol. 24, 9414-9423
77. Sibbing, D., Pfeufer, A., Perisic, T., Mannes, A. M., Fritz-Wolf, K., Unwin, S., Sinner, M. F., Gieger, C., Gloeckner, C. J., Wichmann, H. E., Kremmer, E., Schäfer, Z., Walch, A., Hinterseer, M., Näbauer, M., Kääb, S., Kastrati, A., Schömig, A., Meitinger, T., Bornkamm, G. W., Conrad, M., and von Beckerath, N. (2011) Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. Eur. Heart J. 32, 1121-1133
78. Prasad, R., Chan, L. F., Hughes, C. R., Kaski, J. P., Kowalczyk, J. C., Savage, M.O., Peters, C. J., Nathwani, N., Clark, A. J., Storr, H.L., and Metherell, L. A. (2014) Thioredoxin reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD). J. Clin. Endocrinol. Metab. 99, E1556-E1563
79. Holzerova, E., Danhauser, K., Haack, T. B., Kremer, L. S., Melcher, M., Ingold, I., Kobayashi, S., Terrile, C., Wolf, P., Schaper, J., Mayatepek, E., Baertling, F., Friedmann Angeli, J. P., Conrad, M., Strom, T.M., Meitinger, T., Prokisch, H., and Distelmaier, F. (2016) Human thioredoxin 2 deficiency impairs mitochondrial redox homeostasis and causes early-onset neurodegeneration. Brain 139, 346-354
80. Soerensen, J., Jakupoglu, C., Beck, H., Förster, H., Schmidt, J., Schmahl, W., Schweizer, U., Conrad, M., and Brielmeier, M. (2008) The role of thioredoxin reductases in brain development. PLoS One 3, e1813
81. Mondal, S., Raja, K., Schweizer, U., and Mugesh, G. (2016) Chemistry and biology in the biosynthesis and action of thyroid hormones. Angew. Chem. Int. Ed. Engl. 55, 7606-7630
82. Schneider, M. J., Fiering, S. N., Thai, B., Wu, S. Y., St Germain, E., Parlow, A. F., St Germain, D. L., and Galton, V. A. (2006) Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes inthyroid hormone economyin mice. Endocrinology 147, 580-589
83. Schneider, M. J., Fiering, S. N., Pallud, S. E., Parlow, A. F., St Germain, D. L., and Galton, V. A. (2001) Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol. Endocrinol. 15, 2137-2148
84. Ng, L., Goodyear, R. J., Woods, C.A., Schneider, M. J., Diamond, E., Richardson, G. P., Kelley, M. W., Germain, D. L., Galton, V. A., and Forrest, D. (2004)Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proc.Natl. Acad. Sci. USA 101, 3474-3479
85. Ng, L., Hernandez, A., He, W., Ren, T., Srinivas, M., Ma, M., Galton, V. A., St Germain, D. L., and Forrest, D. (2009) A protective role for type 3 deiodinase, a thyroid hormone-inactivating enzyme, in cochlear development and auditory function. Endocrinology 150, 1952-1960
86. Ng, L., Lyubarsky, A., Nikonov, S. S., Ma, M., Srinivas, M., Kefas, B., St Germain, D. L., Hernandez, A., Pugh, E. N., Jr., and Forrest, D. (2010) Type 3 deiodinase, a thyroid-hormone-inactivating enzyme, controls survival andmaturation of cone photoreceptors. J. Neurosci. 30, 3347-3357
87. Bassett, J.H., Boyde, A., Howell, P.G., Bassett, R.H., Galliford, T.M., Archanco, M., Evans, H., Lawson, M. A., Croucher, P., St Germain, D. L., Galton, V. A., and Williams, G. R. (2010) Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc. Natl. Acad. Sci. USA 107, 7604-7609
88. Moreno-Reyes, R., Suetens, C., Mathieu, F., Begaux, F., Zhu, D., Rivera, M. T., Boelaert, M., Néve, J., Perlmutter, N., and Vanderpas, J. (1998) Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N. Engl. J. Med. 339, 1112-1120
89. Downey, C. M., Horton, C. R., Carlson, B. A., Parsons, T. E., Hatfield, D. L., Hallgŕimsson, B., and Jirik, F. R. (2009) Osteochondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: A putativemodel for Kashin-Beck disease. PLoS Genet. 5, e1000616
90. Dumitrescu, A. M., Liao, X. H., Abdullah, M. S., Lado-Abeal, J., Majed, F. A., Moeller, L. C., Boran, G., Schomburg, L., Weiss, R. E., and Refetoff, S. (2005) Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat. Genet. 37, 1247-1252
91. Dumitrescu, A. M., and Refetoff, S. (2013) The syndromes of reduced sensitivity to thyroid hormone. Biochim. Biophys. Acta 1830, 3987-4003
92. Mehta, A., Rebsch, C.M., Kinzy, S. A., Fletcher, J. E., and Copeland, P. R. (2004) Efficiency ofmammalian selenocysteine incorporation. J. Biol. Chem. 279, 37852-37859
93. Di Cosmo, C., McLellan, N., Liao, X. H., Khanna, K. K., Weiss, R. E., Papp, L., and Refetoff, S. (2009) Clinical and molecular characterization of a novel selenocysteine insertion sequencebinding protein 2 (SBP2) gene mutation (R128X). J. Clin. Endocrinol. Metab. 94, 4003-4009
94. Azevedo, M. F., Barra, G. B., Naves, L. A., Ribeiro Velasco, L. F., Godoy Garcia Castro, P., de Castro, L. C., Amato, A. A., Miniard, A., Driscoll, D., Schomburg, L., and de Assis Rocha Neves, F. (2010) Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J. Clin. Endocrinol. Metab. 95, 4066-4071
95. Hamajima, T., Mushimoto, Y., Kobayashi, H., Saito, Y., and Onigata, K. (2012) Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation. Eur. J. Endocrinol. 166, 757-764
96. Schoenmakers, E., Agostini, M., Mitchell, C., Schoenmakers, N., Papp, L., Rajanayagam, O., Padidela, R., Ceron-Gutierrez, L., Doffinger, R., Prevosto, C., Luan, J., Montano, S., Lu, J., Castanet, M., Clemons, N., Groeneveld, M., Castets, P., Karbaschi, M., Aitken, S., Dixon, A., Williams, J., Campi, I., Blount, M., Burton, H., Muntoni, F., O'Donovan, D., Dean, A., Warren, A., Brierley, C., Baguley, D., Guicheney, P., Fitzgerald, R., Coles, A., Gaston, H., Todd, P., Holmgren, A., Khanna, K. K., Cooke, M., Semple, R., Halsall, D., Wareham, N., Schwabe, J., Grasso, L., Beck-Peccoz, P., Ogunko, A., Dattani, M., Gurnell, M., and Chatterjee, K. (2010)Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J. Clin. Invest. 120, 4220-4235
97. Ursini, F., Heim, S., Kiess, M., Maiorino, M., Roveri, A., Wissing, J., and Flohe, L. (1999) Dual function of the selenoprotein PHGPx during sperm maturation. Science 285, 1393-1396
98. Schoenmakers, E., Carlson, B., Agostini, M., Moran, C., Rajanayagam, O., Bochukova, E., Tobe, R., Peat, R., Gevers, E., Muntoni, F., Guicheney, P., Schoenmakers, N., Farooqi, S., Lyons, G., Hatfield, D., and Chatterjee, K. (2016) Mutation in human selenocysteine transfer RNA selectively disrupts selenoprotein synthesis. J. Clin. Invest. 126, 992-996
99. Fradejas, N., Carlson, B. A., Rijntjes, E., Becker, N. P., Tobe, R., and Schweizer, U. (2013) Mammalian Trit1 is a tRNA([Ser]Sec)-isopentenyl transferase required for full selenoprotein expression. Biochem. J. 450, 427-432
100. Yarham, J. W., Lamichhane, T. N., Pyle, A., Mattijssen, S., Baruffini, E., Bruni, F., Donnini, C., Vassilev, A., He, L., Blakely, E. L., Griffin, H., Santibanez-Koref, M., Bindoff, L. A., Ferrero, I., Chinnery, P. F., McFarland, R., Maraia, R. J., and Taylor, R. W. (2014) Defective i6A37 modification of mitochondrial and cytosolic tRNAs results from pathogenic mutations in TRIT1 and its substrate tRNA. PLoS Genet. 10, e1004424
101. Makrythanasis, P., Nelis, M., Santoni, F. A., Guipponi, M., Vannier, A., Bena, F., Gimelli, S., Stathaki, E., Temtamy, S., Megarbańe, A., Masri, A., Aglan, M. S., Zaki, M. S., Bottani, A., Fokstuen, S., Gwanmesia, L., Aliferis, K., Bustamante Eduardo, M., Stamoulis, G., Psoni, S., Kitsiou-Tzeli, S., Fryssira, H., Kanavakis, E., Al-Allawi, N., Sefiani, A., Al Hait, S., Elalaoui, S. C., Jalkh, N., Al-Gazali, L., Al-Jasmi, F., Bouhamed, H. C., Abdalla, E., Cooper, D. N., Hamamy, H., and Antonarakis, S. E. (2014) Diagnostic exome sequencing to elucidate the genetic basis of likely recessive disorders in consanguineous families. Hum. Mutat. 35, 1203-1210
102. Alazami, A. M., Patel, N., Shamseldin, H. E., Anazi, S., Al-Dosari, M. S., Alzahrani, F., Hijazi, H., Alshammari, M., Aldahmesh, M. A., Salih, M. A., Faqeih, E., Alhashem, A., Bashiri, F. A., Al-Owain, M., Kentab, A. Y., Sogaty, S., Al Tala, S., Temsah, M. H., Tulbah, M., Aljelaify, R. F., Alshahwan, S. A., Seidahmed, M. Z., Alhadid, A. A., Aldhalaan, H., AlQallaf, F., Kurdi, W., Alfadhel, M., Babay, Z., Alsogheer, M., Kaya, N., Al-Hassnan, Z. N., Abdel-Salam, G. M., Al-Sannaa, N., Al Mutairi, F., El Khashab, H. Y., Bohlega, S., Jia, X., Nguyen, H. C., Hammami, R., Adly, N., Mohamed, J. Y., Abdulwahab, F., Ibrahim, N., Naim, E. A., Al-Younes, B., Meyer, B. F., Hashem, M., Shaheen, R., Xiong, Y., Abouelhoda, M., Aldeeri, A. A., Monies, D. M., and Alkuraya, F. S. (2015) Accelerating novel candidate gene discovery in neurogenetic disorders via wholeexome sequencing of prescreened multiplex consanguineous families. Cell Reports 10, 148-161
103. Zhu, X., Petrovski, S., Xie, P., Ruzzo, E. K., Lu, Y. F., McSweeney, K. M., Ben-Zeev, B., Nissenkorn, A., Anikster, Y., Oz-Levi, D., Dhindsa, R. S., Hitomi, Y., Schoch, K., Spillmann, R. C., Heimer, G., Marek-Yagel, D., Tzadok, M., Han, Y., Worley, G., Goldstein, J., Jiang, Y. H., Lancet, D., Pras, E., Shashi, V., McHale, D., Need, A. C., and Goldstein, D. B. (2015) Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genet. Med. 17, 774-781